[Skip header]
Patron: Her Majesty the Queen
RSSA coat of arms

The Royal Scottish Society of Arts
Showcasing Scotland's Science, Technology and Innovation

Home
Contacts Search
☰ Menu
Home About the Society Events Fellowship Governance Contacts Search

7th Meeting of the 200th Session (2020-2021)

What are the prospects for regenerative neurology?

Professor Siddharthan Chandran

Professor Siddharthan Chandran

Professor Siddharthan Chandran FRSE
Director of Centre for Clinical Brain Sciences, Edinburgh Neuroscience,
Euan MacDonald Centre and Anne Rowling Regenerative Neurology Clinic

On Monday 26th April 2021, at 7pm

Disorders of the brain across the life course are a major public health threat. Despite many advances in medicine, meaningful therapeutics - including for conditions of the ageing brain such as the dementias - remain rare. The reasons why will be explored and prospects for change will be considered with an emphasis on the impact of exciting and disruptive new technologies.

Siddharthan Chandran trained in medicine at Southampton University, subsequently undertaking neurology training at the National Hospital for Neurology and Neurosurgery, London, and Cambridge. He was awarded a PhD in developmental neurobiology in 2000 from the University of Cambridge. His previous appointments have included Consultant Neurologist, University Lecturer and Fellow of Kings College at the University of Cambridge. In 2009, he became MacDonald Professor of Neurology at The University of Edinburgh where he is now Dean of Clinical Medicine and holds Directorships of the Anne Rowling Regenerative Neurology Clinic and the Euan MacDonald Centre alongside the University institute Edinburgh Neuroscience.

The goal of Professor Chandran's research, that combines laboratory and clinical activity, is in the emerging medical discipline of Regenerative Neurology. His particular expertise is in the use of human / patient stem cells to model aspects of brain diseases across the life-course as well as early proof of concept clinical trials.